Neurology Edition: Top Headlines for Week of May 30, 2022

In this week’s edition, anxiety, depression worse among older men with vision impairment; emerging therapeutics may improve outcomes in pediatric patients with rare disorders; glioblastoma presents roadblock to successful immunotherapy; and more.

Read the full coverage here:

MRI findings key pathology markers of 4R-tauopathies

Emerging therapeutics may improve outcomes in pediatric patients with rare disorders

Together Senior Health launches platform to reduce memory loss in AD, dementia

Anxiety, depression worse among older men with vision impairment

Glioblastoma presents roadblock to successful immunotherapy

References:

Carlos AF, et al. Tau histopathological lesion type correlates of structural magnetic resonance imaging and diffusion tensor imaging biomarkers in 4-repeat tauopathies. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.

Emrick L, et al. Emerging therapeutics for rare pediatric genetic disorders. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.

Press Release

Gascoyne B, et al. Int Health. 2022;doi:10.1093/inthealth/ihab070

Kumthekar P. AAN year in review: neuro oncology. Presented at: American Academy of Neurology annual meeting; April 2-7, 2022; Seattle.